Marijuana Law, Policy & Reform

Editor: Douglas A. Berman
Moritz College of Law

Sunday, November 26, 2017

Taking a close look at "Big Pharma's Anti-Marijuana Campaign"

As mentioned in a prior post, my Marijuana Law, Policy & Reform seminar is hitting its homestretch and the last group of students are delivering presentations on a marijuana-related topic of their choosing. One student for the next class will be looking at what she is calling "Big Pharma's Anti-Marijuana Campaign."  Here is how she has explained her plans, following by links to background information regarding the topic:

My presentation will reveal how Big Pharma contributes to the Opioid Epidemic, how marijuana can be used as a substitute for opioids, how the legalization of medical marijuana threatens the bottom lines of pharmaceutical giants, and how these corporations have subsequently opposed pro-pot legislation.

NIH data on "Overdose Death Rates"

"Can Medical Marijuana Help End the Opioid Epidemic?"

"Patients Are Ditching Opioid Pills for Weed: Can marijuana help solve the opioid epidemic?"

"Is Big Pharma Out to Stop — Or Take Over — Marijuana Legalization?"

"The Real Reason Pot Is Still Illegal: Opponents of marijuana-law reform insist that legalization is dangerous — but the biggest threat is to their own bottom line."

http://lawprofessors.typepad.com/marijuana_law/2017/11/take-a-close-look-at-big-pharmas-anti-marijuana-campaign.html

Business laws and regulatory issues, Medical community perspectives, Medical Marijuana Commentary and Debate, Recreational Marijuana Commentary and Debate, Who decides | Permalink

Comments

Post a comment